Literature DB >> 16217276

Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.

Shigeru Satoh1, Norihiko Tsuchiya, Tomonori Habuchi, Takeshi Ishiyama, Koji Seimo, Tetsuro Kato.   

Abstract

PURPOSE: We verified differences in the incidence, clinical characteristics and outcomes between patients on chronic dialysis for end stage renal disease with renal cell carcinoma (RCC) and those with transitional cell carcinoma (TCC).
MATERIALS AND METHODS: Data regarding RCC and TCC were reviewed in the medical records of 6,201 patients with end stage renal disease who underwent chronic dialysis between January 1990 and June 2003 in our 38 affiliated dialysis centers, and data were compared with those reported in Australia and New Zealand.
RESULTS: Among the patients RCC developed in 38 (0.61%) and TCC developed in 16 (0.26%) during maintenance dialysis. The primary renal disease was chronic glomerulonephritis in patients with RCC (68.4%) and diabetic nephropathy in patients with TCC (43.8%, p = 0.002). Mean patient age at initiation of dialysis was 45 years for those with RCC and 63 for those with TCC (p < 0.001). Mean interval from dialysis induction to tumor diagnosis was 143 months for patients with RCC and 54 months for patients with TCC (p < 0.001). Of 38 RCCs 23 (60.5%) were incidentally detected by regular abdominal imaging examinations while painless gross hematuria was the cardinal symptom in 13 (81.2%) of 16 TCCs. Overall and cancer specific survivals after tumor diagnosis were significantly superior in patients with RCC compared to those with TCC (p = 0.0001 and p = 0.0003, respectively), and the cancer specific 5-year survival was 88.9% for RCC and 29.5% for TCC. In both cancers tumor stage significantly increased the risk of cancer specific death. Compared with patients from Australia and New Zealand, the incidence of RCC was higher and that of TCC was lower in our patients (p <0.001).
CONCLUSIONS: In the Japanese population on dialysis RCC is more common than TCC. Since long-term dialysis is a risk factor for RCC, regular imaging examinations may have contributed to the favorable outcome of our patients on dialysis with RCC. In contrast, the unfavorable outcome of TCC suggests the need for effective diagnostic measures for early detection of TCC in patients on dialysis.

Entities:  

Mesh:

Year:  2005        PMID: 16217276     DOI: 10.1097/01.ju.0000177489.98031.54

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.

Authors:  Shu-Fen Tseng; Yao-Chi Chuang; Wen-Chou Yang
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

Review 2.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

3.  Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.

Authors:  Yasuyuki Sato; Tsunenori Kondo; Toshio Takagi; Iizuka Junpei; Kazunari Tanabe
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

4.  Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias.

Authors:  Carolina Muriel; Emilio Esteban; Norberto Corral; Paula J Fonseca; María Luque; José Pablo Berros; Yolanda Fernández; Pilar Blay; Joaquín Fra; Noemí Villanueva; Miguel Sanmamed; Pablo Pardo; Marta Izquierdo; José María Vieitez; Enrique Estrada; Ángel J Lacave
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

5.  Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer.

Authors:  Chien-Hui Ou; Wen-Horng Yang
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

6.  Wide range and variation in minimally invasive surgery for renal malignancy in Japan: a population-based analysis.

Authors:  Toru Sugihara; Hideo Yasunaga; Hiromasa Horiguchi; Nobuo Tsuru; Tetsuya Fujimura; Hiroaki Nishimatsu; Haruki Kume; Kazuhiko Ohe; Shinya Matsuda; Kiyohide Fushimi; Yukio Homma
Journal:  Int J Clin Oncol       Date:  2012-11-23       Impact factor: 3.402

7.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

8.  Transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients.

Authors:  Vital Hevia; Victoria Gómez; Sara Alvarez; Víctor Díez Nicolás; Carmen Gómez Del Cañizo; Andrea Orosa; Cristina Galeano Álvarez; F J Burgos Revilla
Journal:  Case Rep Transplant       Date:  2013-05-26

9.  Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.

Authors:  Grzegorz Kade; Arkadiusz Lubas; Lubomir Bodnar; Cezary Szczylik; Zofia Wańkowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20

Review 10.  Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Authors:  Li-Jen Wang; Shen-Yang Lee; Bin Tean Teh; Cheng-Keng Chuang; Joëlle Nortier
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.